using-an-isolated-working-rat-heart-model-to-test-donor-heart

Using an Isolated Working Rat Heart Model to Test Donor Heart Preservation Strategies

Optimization of donor heart preservation solutions has played a key role in reducing ischemia-reperfusion injury in donor hearts during organ retrieval, ...

phosphorus-31-magnetic-resonance-spectroscopy-for-serial-measurements

Phosphorus-31 Magnetic Resonance Spectroscopy for Serial Measurements of Cardiac Energetics During Temperature-Controlled Heart Preservation

Reliable organ preservation is critical to increasing donor availability and improving transplant outcomes. While static storage remains the standard for ...

Victor Chang Cardiac Research Institute

University of New South Wales

Johns Hopkins University School of Medicine

Ischemia-reperfusion injury (IRI) is one of the major risk factors implicated in morbidity and mortality associated with cardiovascular disease. During cardiac ischemia, the buildup of acidic metabolites results in decreased intracellular and extracellular pH, which can reach as low as 6.0 to 6.5. The resulting tissue acidosis exacerbates ischemic injury and significantly affects cardiac function.

Therapeutic Inhibition of Acid-Sensing Ion Channel 1a Recovers Heart Function After Ischemia-Reperfusion Injury.

Frailty is prevalent in patients with heart failure (HF) and associated with increased morbidity and mortality. Hence, there has been increased interest in the reversibility of frailty following treatment with medication or surgery. This systematic review aimed to assess the reversibility of frailty in patients with HF before and after surgical interventions aimed at treating the underlying cause of HF. It also aimed to assess the efficacy of cardiac rehabilitation and prehabilitation in reversing or preventing frailty in patients with HF.

Prevention and Reversal of Frailty in Heart Failure　- A Systematic Review.

Heart transplantation from donation after circulatory death (DCD) donors has the potential to substantially increase overall heart transplant activity. The aim of this report is to review the first 8 y of our clinical heart transplant program at St Vincent's Hospital Sydney, to describe how our program has evolved and to report the impact that changes to our retrieval protocols have had on posttransplant outcomes. Since 2014, we have performed 74 DCD heart transplants from DCD donors utilizing a direct procurement protocol followed by normothermic machine perfusion. Changes to our retrieval protocol have resulted in a higher retrieval rate from DCD donors and fewer rejections of DCD hearts during normothermic machine perfusion. Compared with our previously reported early experience in the first 23 transplants, we have observed a significant reduction in the incidence of severe primary graft dysfunction from 35% (8/23) to 8% (4/51) in the subsequent 51 transplant recipients ( P < 0.01). The only withdrawal time interval significantly associated with severe primary graft dysfunction was the asystolic warm ischemic time: 15 (12-17) versus 13 (11-14) min ( P < 0.05). One- and 5-y survival of DCD heart transplant recipients was 94% and 88%, comparable to that of a contemporary cohort of donation after brain death recipients: 87 and 81% ( P -value was not significant). In conclusion, heart transplantation from DCD donors has become a major contributor to our overall transplant activity accounting for almost 30% of all transplants performed by our program in the last 2 y, with similar DCD and donation after brain death outcomes.

Heart Transplantation From DCD Donors in Australia: Lessons Learned From the First 74 Cases.

To highlight the current global experience with DCD heart transplantation and explore the evolution of, and compare preservation strategies; examine early clinical outcomes, and discuss the growing use of DCD donors as a new frontier in heart transplantation.

Donation After Circulatory Death: A New Frontier.

To determine safety and feasibility of ex-situ coronary angiography.

ArticleTotal : 2	Year
Publication title	2024
Publication title	2026

Article	Year
Therapeutic Inhibition of Acid-Sensing Ion Channel 1a Recovers Heart Function After Ischemia-Reperfusion Injury. Circulation\| PubMed ID: 34264749	2021
Prevention and Reversal of Frailty in Heart Failure　- A Systematic Review. Circulation journal : official journal of the Japanese Circulation Society\| PubMed ID: 34707071	2021
Heart Transplantation From DCD Donors in Australia: Lessons Learned From the First 74 Cases. Transplantation\| PubMed ID: 36044329	2023
Donation After Circulatory Death: A New Frontier. Current cardiology reports\| PubMed ID: 36272050	2022
Coronary angiography of the ex-situ beating donor heart in a portable organ care system. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions\| PubMed ID: 36321629	2022
Exploring the limits of ex situ heart perfusion. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons\| PubMed ID: 36754258	2023
Heart Transplantation From DCD Donors Enters the Mainstream. Transplantation\| PubMed ID: 38010153	2023
The search continues: investigating potential biomarkers to predict cardiac allograft function from donation after circulatory death donors. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation\| PubMed ID: 39353480	2024
Rare but Necessary: A Defense of Organ Allocation Out of Sequence in Heart Transplantation. The American journal of bioethics : AJOB\| PubMed ID: 41533119	2026

Yashutosh Joshi

Biography

JoVE Journal Publications

Other Publications